Patrons
Cihlář family
"We deeply respect Neuron Endowment Fund and its work. The way they support young talented scientists. It is my pleasure to support Czech research."

Tomáš Cihlář is a Czech biochemist known for his role in the development of remdesivir. A specialist in virology, Cihlář holds the positions of Senior Director, Biology, and Vice-President at American pharmaceutical company Gilead Sciences.
As a student, Cihlář assisted fellow biochemist Antonín Holý in developing Viread, the primary drug used to fight HIV infection.